Warning letter
Magellan Rx Pharmacy, LLC: warning letter of Sep 11, 2017
FDA warning letter 536134 · New Jersey District Office
Key facts
| Reference number | 536134 |
|---|---|
| Company | Magellan Rx Pharmacy, LLC |
| Subject | Drug Product/Adulterated |
| Issue date | Sep 11, 2017 |
| Posted date | Sep 11, 2017 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| Inspection city | Astoria |
| Inspection ZIP | 11106 |
| Inspection start date | Dec 6, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: